Mesoblastic nephroma overview

Jump to navigation Jump to search

Mesoblastic nephroma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mesoblastic nephroma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Biopsy

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mesoblastic nephroma overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mesoblastic nephroma overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mesoblastic nephroma overview

CDC on Mesoblastic nephroma overview

Mesoblastic nephroma overview in the news

Blogs on Mesoblastic nephroma overview

Directions to Hospitals Treating Mesoblastic nephroma

Risk calculators and risk factors for Mesoblastic nephroma overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]

Overview

Mesoblastic nephroma is a type of kidney tumor. Mesoblastic nephroma is a rare disease that tends to affect children under 3 years of age, especially neonates.[1][2] The male to female ratio is approximately 2 to 1.[3] Mesoblastic nephroma may be classified according to pathology into three subtypes: classic, cellular, and mixed mesoblastic nephroma.[4] Mesoblastic nephroma may be caused by translocation t(12:15)(p13;q25) that generates the fusion of ETV6/NTRK3 gene.[5] On gross pathology, a solid nonencapsulated mass that often occurs near the renal hilum is the characteristic finding of mesoblastic nephroma. On microscopic histopathological analysis, spindle cell is the characteristic finding of classic mesoblastic nephroma; whereas, plump cells with vesicular nuclei is the characteristic finding of cellular mesoblastic nephroma.[6] Mesoblastic nephroma must be differentiated from rhabdoid tumor, clear cell sarcoma of the kidney, and Wilm's tumor. Symptoms of mesoblastic nephroma include polyhydramnios, hematuria, and abdominal distension. Biopsy is helpful in the diagnosis of mesoblastic nephroma. The predominant therapy for mesoblastic nephroma is surgical resection. Adjunctive chemotherapy may be required for cellular mesoblastic nephroma.[4] Prognosis is generally excellent, and the 5-year survival rate of patients with mesoblastic nephroma is approximately 96%.[7]

Classification

Mesoblastic nephroma may be classified according to pathology into three subtypes: classic, cellular, and mixed mesoblastic nephroma.[4]

Pathophysiology

On gross pathology, a solid nonencapsulated mass that often occurs near the renal hilum is the characteristic finding of mesoblastic nephroma. On microscopic histopathological analysis, spindle cell is the characteristic finding of classic mesoblastic nephroma; whereas, plump cells with vesicular nuclei is the characteristic finding of cellular mesoblastic nephroma.[8]

Causes

Mesoblastic nephroma may be caused by translocation t(12:15)(p13;q25) that generates the fusion of ETV6/NTRK3 gene.[5]

Differential diagnosis

Mesoblastic nephroma must be differentiated from rhabdoid tumor, clear cell sarcoma of the kidney, and Wilm's tumor.

Epidemiology and Demographics

Mesoblastic nephroma is a rare disease that tends to affect children under 3 years of age, especially neonates. [1][9] The male to female ratio is approximately 2 to 1.[3]

Risk Factors

There are no established risk factors for mesoblastic nephroma.

Screening

According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for mesoblastic nephroma.[10]

Complications and Prognosis

Complications of mesoblastic nephroma include stillbirth, shoulder dystocia at birth, hydrops fetalis, and respiratory distress syndrome. Prognosis is generally excellent, and the 5-year survival rate of patients with mesoblastic nephroma is approximately 96%.[7]

Staging

There is no established system for the staging of mesoblastic nephroma.

Diagnosis

Symptoms

Symptoms of mesoblastic nephroma include polyhydramnios, hematuria, and abdominal distension.

Physical Examination

Common physical examination findings of mesoblastic nephroma include pallor and an palpated abdominal mass.

Laboratory Findings

There are no laboratory findings associated with mesoblastic nephroma.

X Ray

Abdominal X-ray may be helpful in the diagnosis of mesoblastic nephroma.

CT Scan

CT scan may be helpful in the diagnosis of mesoblastic nephroma.

MRI

MRI may be helpful in the diagnosis of mesoblastic nephroma.

Ultrasound

Ultrasound may be helpful in the diagnosis of mesoblastic nephroma.

Other Imaging Findings

There are no other imaging findings associated with mesoblastic nephroma.

Other Diagnostic Studies

There are no other diagnostic study findings associated with mesoblastic nephroma.

Biopsy

Biopsy is helpful in the diagnosis of mesoblastic nephroma.

Treatment

Medical Therapy

The predominant therapy for mesoblastic nephroma is surgical resection. Adjunctive chemotherapy may be required for cellular mesoblastic nephroma.[4]

Surgery

Surgery is the mainstay of treatment for mesoblastic nephroma.

Primary Prevention

There is no established method for prevention of mesoblastic nephroma.

Secondary Prevention

There are no secondary preventive measures available for mesoblastic nephroma.

References

  1. 1.0 1.1 Mesoblastic nephroma.Dr Ayush Goel and Dr Yuranga Weerakkody et al. Radiopaedia.org 2015. http://radiopaedia.org/articles/mesoblastic-nephroma
  2. Tavassoli, Fattaneh (2003). Pathology and genetics of tumours of the breast and female genital organs. Lyon: IAPS Press. ISBN 9283224124.
  3. 3.0 3.1 Furtwaengler R, Reinhard H, Leuschner I, Schenk JP, Goebel U, Claviez A; et al. (2006). "Mesoblastic nephroma--a report from the Gesellschaft fur Pädiatrische Onkologie und Hämatologie (GPOH)". Cancer. 106 (10): 2275–83. doi:10.1002/cncr.21836. PMID 16596620.
  4. 4.0 4.1 4.2 4.3 Malkan AD, Loh A, Bahrami A, et al. (2015). "An approach to renal masses in pediatrics". Pediatrics. 135 (1): 142–58. doi:10.1542/peds.2014-1011. PMID 25452658.
  5. 5.0 5.1 Knezevich SR, McFadden DE, Tao W, Lim JF, Sorensen PH (1998). "A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma". Nature Genetics. 18 (2): 184–7. doi:10.1038/ng0298-184. PMID 9462753.
  6. Humphrey, Peter (2008). The Washington manual of surgical pathology. Philadelphia: Lippincott Williams & Wilkins. ISBN 978-0781765275.
  7. 7.0 7.1 van den Heuvel-Eibrink MM, Grundy P, Graf N, Pritchard-Jones K, Bergeron C, Patte C; et al. (2008). "Characteristics and survival of 750 children diagnosed with a renal tumor in the first seven months of life: A collaborative study by the SIOP/GPOH/SFOP, NWTSG, and UKCCSG Wilms tumor study groups". Pediatr Blood Cancer. 50 (6): 1130–4. doi:10.1002/pbc.21389. PMID 18095319.
  8. Humphrey, Peter (2008). The Washington manual of surgical pathology. Philadelphia: Lippincott Williams & Wilkins. ISBN 978-0781765275.
  9. Tavassoli, Fattaneh (2003). Pathology and genetics of tumours of the breast and female genital organs. Lyon: IAPS Press. ISBN 9283224124.
  10. Mesoblastic nephroma. U.S. Preventive Service Task Force (USPSTF) 2015. http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=mesoblastic+nephroma Accessed on November, 3, 2015

Template:WH Template:WS